Equity
AOCI
Pfizer AOCI increased by 10.7% to -$7.2B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.1%, from -$8.58B to -$7.2B. Over 5 years (FY 2020 to FY 2025), AOCI shows a downward trend with a 8.7% CAGR.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryRisk
SignalContext dependent
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026May 5, 2026
How to read this metric
Positive values indicate unrealized gains in assets or favorable currency impacts, while negative values reflect unrealized losses or unfavorable currency movements.
Detailed definition
Accumulated Other Comprehensive Income (AOCI) captures unrealized gains or losses that are excluded from the net income...
Peer comparison
Multinational corporations with significant global operations often show higher volatility in AOCI due to currency translation effects.
Metric ID:
aociHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$4.76B | -$5.65B | -$5.9B | -$6.16B | -$7.12B | -$8.23B | -$8.3B | -$8.29B | -$8.1B | -$7.97B | -$7.96B | -$7.76B | -$7.82B | -$7.97B | -$7.84B | -$8.58B | -$8.44B | -$8.07B | -$8.07B | -$7.2B |
| QoQ Change | — | -18.7% | -4.4% | -4.4% | -15.6% | -15.5% | -1.0% | +0.2% | +2.3% | +1.7% | +0.1% | +2.5% | -0.7% | -2.0% | +1.6% | -9.4% | +1.7% | +4.4% | -0.0% | +10.7% |
| YoY Change | — | — | — | — | -49.6% | -45.6% | -40.8% | -34.6% | -13.8% | +3.1% | +4.1% | +6.4% | +3.5% | -0.1% | +1.5% | -10.6% | -8.0% | -1.2% | -2.9% | +16.1% |
Range-$8.58B – -$4.76B
CAGR+9.1%
Avg YoY Growth-10.8%
Median YoY Growth-2.0%
AOCI at Other Companies
Frequently Asked Questions
- What is Pfizer's aoci?
- Pfizer (PFE) reported aoci of -$7.2B in Q1 2026.
- How has Pfizer's aoci changed year-over-year?
- Pfizer's aoci increased by 16.1% year-over-year, from -$8.58B to -$7.2B.
- What is the long-term trend for Pfizer's aoci?
- Over 5 years (2020 to 2025), Pfizer's aoci has grown at a 8.7% compound annual growth rate (CAGR), from -$5.31B to -$8.07B.
- What does aoci mean?
- A collection of unrealized gains and losses that bypass the income statement, often related to currency changes or pension adjustments.